We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Fast Tracks Drug for Radiation Enteritis
FDA Fast Tracks Drug for Radiation Enteritis
January 9, 2009
DOR BioPharma has received FDA fast-track status for DOR201, which it is developing to prevent acute radiation enteritis, a side effect of radiation therapy for cancer, according to the company.